Searched for
VERO CELL
Bharat Biotech's partner seeks Covaxin nod in US for children between 2 and 18 yearsThe US-based firm has applied for the authorisation based on the basis of the results of phase 2 and 3 clinical trials conducted on 526 chi...- Bharat Biotech's US partner Ocugen files request with FDA for Covaxin trialsThe US firm in a press release said the Phase 3 trial, proposed in the IND, is designed to establish whether the immune response experience...
- Social media posts twisted facts, final product doesn't have newborn calf serum: Centre on CovaxinNewborn calf serum is used only for the preparation and growth of vero cells. Serum from bovine and other animal are standard enrichment in...
- Ex-ICMR DG clears the air on Covaxin's phase-3 trial data and delay in WHO approval"It was foolish to apply to US FDA for approval because even in the emergency authorisation vaccine guidelines you have to complete phase t...
- Bharat Biotech raises Covaxin capacity by another 200 million doses a year“The company plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production ...
- Bharat Biotech to ramp up Covaxin production by additional 200 million doses"The company plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production ...
- Bharat Biotech approaches DCGI, seeks Covaxin's removal from 'clinical trial mode'The vaccine was granted approval “for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial...
- People with fever, pregnant and breastfeeding women avoid Covaxin, says Bharat BiotechThe vaccine maker in the fact sheet on Covaxin, posted in its website, said the clinical efficacy of the vaccine is yet to be established a...
- Bharat Biotech to pay compensation if Covaxin causes side effects
- Now, Covaxin to be tested on toddlers as young as 2 yearsCovaxin, being developed by Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, was...
- Masks probably may never even go, says ICMR chief Balram Bhargava"We don't know how much of the population we'll have to vaccinate to break the virus transmission. What we know is that we've been able to ...
- A great milestone in India's scientific capability: Bharat Biotech on approval for emergency use of CovaxinThe approval of Covaxin for emergency use is a giant leap for innovation and novel product development in India, Krishna Ella, Chairman and...
- India successfully isolates and cultures UK-variant of coronavirus strain: ICMRCulture is the process by which cells are grown under controlled conditions, generally outside their natural environment.
- Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of CovaxinBharat Biotech has signed up 13,000 volunteers for the Phase 3 trial, backed by India's government medical research body, and is progressin...
- Repurposed anti-protozoal drug emetine effective against Covid: Indian scientistsScientists at National Centre for Veterinary Type Cultures have a unique collection of over 100 small molecule chemical inhibitors that are...
- Bharat Biotech begins Phase-III trials for COVID-19 vaccine, Covaxin, with 26,000 volunteers"This is India's first phase-III efficacy study for a Covid-19 vaccine, and the largest phase-III efficacy trial ever conducted in India," ...
- New study shows gargling with mouthwash may inactivate coronavirus, lower spread of Covid-19High quantities of the virus particles can be detected in the oral cavity and throat of some COVID-19 patients.
- Odisha: Institute of Life Sciences establishes stable cultures of coronavirusSeventeen virus cultures have been established from swab samples originating from different locations of the country with varying virus loa...
- Bharat Biotech’s Covid vaccine gets DCGI nod for clinical trialsThe SARS-CoV-2 strain was isolated in NIV and transferred to Bharat Biotech, which has developed the indigenous, inactivated vaccine at its...
- Hyderabad company, Australian varsity partner for vaccineScientists from India and Australia will develop a ‘live attenuated SARS – CoV-2 vaccine’ using the latest codon deoptimisation technology,...
Load More
